IMCAS Exclusive Interview, recorded during IMCAS World Congress 2026. What can one of the pioneers of neuromodulators teach us about the evolution of aesthetic medicine today? Join us for a conversation with Dr. Jean Carruthers, oculoplastic surgeon and key figure in the development of neurotoxin use in aesthetics, as she shares the insights practitioners continue to learn from. Together, we explore her approach to patient care, the clinical considerations surrounding neuromodulators, and how the field has transformed over time. Dr. Carruthers reflects on the role physicians play in shaping patient outcomes beyond the technical aspects of treatment, and the importance of maintaining a thoughtful, individualized approach. Listen as she discusses the realities of clinical practice, the lessons gained through decades of experience, and the perspectives that continue to influence aesthetic medicine today. Whether you’re a clinician or simply curious about the origins of neuromodulators, this conversation offers valuable insight and practical guidance.

How are leading practitioners advancing scar treatment through combination therapies and evolving technologies? Join us for a conversation with Dr. Fadi Hamadani to explore the strategies shaping modern scar management. From lasers and energy-based devices to injectables, he shares how integrating multiple modalities can optimize outcomes and elevate patient care. Dr. Hamadani also discusses the broader considerations that influence results, from patient compliance to the importance of continuous physician education. Drawing on his clinical experience and global perspective, he highlights the challenges of treating complex scars as well as the difficulties of ensuring patient compliance, and the lessons learned in refining treatment approaches in both. Whether you’re a clinician or simply interested in the future of scar therapy, this episode offers valuable insights and practical takeaways that hold pearls of wisdom for every listener.

How do top clinicians manage the challenges of GLP-1 therapy while supporting patients’ overall health and appearance? Join us for a conversation with Dr. Suzanne Kilmer, Dr. Orit Markowitz, and Dr. Andreas Nikolis to find the answers practitioners are seeking. Together, they share their experiences treating patients on or after GLP-1 therapy, focusing on how to address secondary symptoms and regain the volume and elasticity needed to restore more youthful appearances post weight loss. Dr. Kilmer, Dr. Markowitz, and Dr. Nikolis share their strategies for handling significant volume loss and skin laxity and reveal the ultimate obstacle can be the patients themselves. Listen as they discuss the real-world complexities of GLP-1 treatment, the lessons learned along the way, and the approaches that are providing promising results. Whether you’re a clinician or someone curious about the impact of GLP-1 on patient care, this conversation offers rare insights and actionable guidance. The study referenced by Dr. Andreas Nikolas can be found here. Consensus Statements on Managing Aesthetic Needs in Prescription Medication‐Driven Weight Loss Patients: An International, Multidisciplinary Delphi Study, published in March 2025, authored by Andreas Nikolas, Kaitlyn Enright, Sabrina G Fabi, Michael Somenek, Hugues Cartier, Luiz Avelar, Johnny Franco, Alessandra Haddad, Maria Magdalini Khattar, Jeff Huang, Tyler Safran, Inna Prygova, Steven Dyan.

What drives a world-changing medical innovator? We had the rare opportunity to sit down with Dr. Richard Rox Anderson, the Harvard professor and visionary dermatologist behind some of the most transformative advancements in laser medicine—including fractional laser technology and cryolipolysis. His work has redefined skin treatments, hair removal, scar reduction, and beyond. In this episode, Dr. Anderson takes us through his journey, from the breakthroughs that changed modern medicine to the challenges that shaped his career. Discover how he turns "Aha!" moments into life-changing innovations—and how he embraces failure as part of the process. This is a conversation you won’t want to miss.